Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 36% ± 14% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 6% | |
oligodendrocyte | 4 studies | 19% ± 2% | |
endothelial cell | 3 studies | 25% ± 7% | |
microglial cell | 3 studies | 16% ± 1% | |
epithelial cell | 3 studies | 21% ± 1% | |
GABAergic neuron | 3 studies | 35% ± 8% | |
transit amplifying cell | 3 studies | 22% ± 4% | |
astrocyte | 3 studies | 27% ± 5% | |
interneuron | 3 studies | 32% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3014.01 | 1445 / 1445 | 100% | 26.24 | 183 / 183 |
skin | 100% | 4116.99 | 1809 / 1809 | 100% | 28.18 | 472 / 472 |
breast | 100% | 2922.06 | 459 / 459 | 100% | 20.61 | 1117 / 1118 |
stomach | 100% | 2288.64 | 359 / 359 | 100% | 22.49 | 285 / 286 |
intestine | 100% | 2748.83 | 966 / 966 | 100% | 21.41 | 525 / 527 |
bladder | 100% | 3210.71 | 21 / 21 | 99% | 16.82 | 501 / 504 |
prostate | 100% | 2865.40 | 245 / 245 | 99% | 16.73 | 499 / 502 |
ovary | 100% | 2756.49 | 180 / 180 | 99% | 17.24 | 426 / 430 |
brain | 99% | 2064.58 | 2622 / 2642 | 100% | 18.97 | 702 / 705 |
uterus | 100% | 4632.42 | 170 / 170 | 99% | 16.12 | 453 / 459 |
lung | 100% | 2560.12 | 576 / 578 | 99% | 18.43 | 1142 / 1155 |
thymus | 100% | 2844.18 | 653 / 653 | 98% | 11.39 | 591 / 605 |
pancreas | 99% | 1761.23 | 326 / 328 | 97% | 11.56 | 173 / 178 |
kidney | 100% | 1969.20 | 89 / 89 | 94% | 10.33 | 851 / 901 |
adrenal gland | 100% | 3411.87 | 258 / 258 | 90% | 9.95 | 208 / 230 |
liver | 100% | 1688.88 | 226 / 226 | 85% | 7.85 | 346 / 406 |
adipose | 100% | 3012.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 24.36 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.73 | 29 / 29 |
muscle | 100% | 3858.19 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2395.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.81 | 1 / 1 |
blood vessel | 100% | 2450.30 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 2066.98 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 47% | 1601.81 | 435 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904750 | Biological process | negative regulation of protein localization to nucleolus |
GO_0006360 | Biological process | transcription by RNA polymerase I |
GO_0005736 | Cellular component | RNA polymerase I complex |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0071667 | Molecular function | DNA/RNA hybrid binding |
GO_0001054 | Molecular function | RNA polymerase I activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0003899 | Molecular function | DNA-directed 5'-3' RNA polymerase activity |
Gene name | POLR1A |
Protein name | RNA polymerase I subunit A DNA-directed RNA polymerase subunit (EC 2.7.7.6) DNA-directed RNA polymerase (EC 2.7.7.6) DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194) |
Synonyms | |
Description | FUNCTION: Catalytic core component of RNA polymerase I (Pol I), a DNA-dependent RNA polymerase which synthesizes ribosomal RNA precursors using the four ribonucleoside triphosphates as substrates. Transcribes 47S pre-rRNAs from multicopy rRNA gene clusters, giving rise to 5.8S, 18S and 28S ribosomal RNAs . Pol I-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol I pre-initiation complex (PIC) is recruited by the selectivity factor 1 (SL1/TIF-IB) complex bound to the core promoter that precedes an rDNA repeat unit. The PIC assembly bends the promoter favoring the formation of the transcription bubble and promoter escape. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Highly processive, assembles in structures referred to as 'Miller trees' where many elongating Pol I complexes queue and transcribe the same rDNA coding regions. At terminator sequences downstream of the rDNA gene, PTRF interacts with Pol I and halts Pol I transcription leading to the release of the RNA transcript and polymerase from the DNA . Forms Pol I active center together with the second largest subunit POLR1B/RPA2. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR1A/RPA1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR1B/RPA2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and the template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate. Has proofreading activity: Pauses and backtracks to allow the cleavage of a missincorporated nucleotide via POLR1H/RPA12. High Pol I processivity is associated with decreased transcription fidelity (By similarity). . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. . |
Accessions | ENST00000263857.11 Q96AG9 ENST00000409681.1 B7ZKR9 ENST00000409024.3 ENST00000424089.5 O95602 Q53T12 B9ZVN9 F2Z3I7 |